Inventor · disambiguated record

Barbora Malecova

Also filed as: MALECOVA BARBORA

25 granted patents·7 pending applications·158 citations·filing 2018–2025

96Inventor score

Technology areasC12N A61K C07D

Files withAVIDITY BIOSCIENCES INC32

Top patents by PatentIndex Score

32 records

0198US11446387B2Compositions and methods of treating muscle dystrophyAVIDITY BIOSCIENCES INC·Filed 2021·Granted Sep 20, 2022·8 cites·14 claims
0298US11253607B2Compositions and methods of treating muscle atrophy and myotonic dystrophyAVIDITY BIOSCIENCES INC·Filed 2020·Granted Feb 22, 2022·7 cites·23 claims
0398US11246941B2Compositions and methods of treating muscle atrophy and myotonic dystrophyAVIDITY BIOSCIENCES INC·Filed 2021·Granted Feb 15, 2022·7 cites·23 claims
0498US10881743B2Compositions and methods of treating muscle atrophy and myotonic dystrophyAVIDITY BIOSCIENCES INC·Filed 2019·Granted Jan 5, 2021·55 cites·16 claims
0597US11707532B2Compositions and methods of treating muscle dystrophyAVIDITY BIOSCIENCES INC·Filed 2022·Granted Jul 25, 2023·3 cites·14 claims
0697US11576980B2Compositions and methods of treating muscle atrophy and myotonic dystrophyAVIDITY BIOSCIENCES INC·Filed 2021·Granted Feb 14, 2023·6 cites·23 claims
0797US11555190B2Compositions and methods of treating Facioscapulohumeral muscular dystrophyAVIDITY BIOSCIENCES INC·Filed 2021·Granted Jan 17, 2023·15 cites·17 claims
0897US11525137B2Compositions and methods of treating Facioscapulohumeral muscular dystrophyAVIDITY BIOSCIENCES INC·Filed 2021·Granted Dec 13, 2022·13 cites·21 claims
0997US11497814B2Compositions and methods of treating muscle atrophy and myotonic dystrophyAVIDITY BIOSCIENCES INC·Filed 2021·Granted Nov 15, 2022·3 cites·30 claims
1096US12049629B2Compositions and methods of treating Facioscapulohumeral muscular dystrophyAVIDITY BIOSCIENCES INC·Filed 2022·Granted Jul 30, 2024·2 cites·22 claims
1196US11999955B2Compositions and methods of treating facioscapulohumeral muscular dystrophyAVIDITY BIOSCIENCES INC·Filed 2022·Granted Jun 4, 2024·2 cites·16 claims
1296US11912779B2Compositions and methods of treating facioscapulohumeral muscular dystrophyAVIDITY BIOSCIENCES INC·Filed 2022·Granted Feb 27, 2024·6 cites·17 claims
1396US11583591B2Compositions and methods of treating muscle atrophy and myotonic dystrophyAVIDITY BIOSCIENCES INC·Filed 2021·Granted Feb 21, 2023·2 cites·14 claims
1496US11554176B2Compositions and methods of treating muscle atrophy and myotonic dystrophyAVIDITY BIOSCIENCES INC·Filed 2021·Granted Jan 17, 2023·2 cites·16 claims
1596US11110180B2Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES INC·Filed 2018·Granted Sep 7, 2021·19 cites·20 claims
1695US12427202B2Compositions and methods of treating muscle dystrophyAVIDITY BIOSCIENCES INC·Filed 2023·Granted Sep 30, 2025·1 cites·9 claims
1795US12157774B2Compositions and methods of treating facioscapulohumeral muscular dystrophyAVIDITY BIOSCIENCES INC·Filed 2024·Granted Dec 3, 2024·1 cites·5 claims
1895US12071485B2Compositions and methods of treating facioscapulohumeral muscular dystrophyAVIDITY BIOSCIENCES INC·Filed 2024·Granted Aug 27, 2024·2 cites·13 claims
1994US12104156B2Compositions and methods of treating facioscapulohumeral muscular dystrophyAVIDITY BIOSCIENCES INC·Filed 2022·Granted Oct 1, 2024·1 cites·16 claims
2094US11872287B2Compositions and methods of treating muscle atrophy and myotonic dystrophyAVIDITY BIOSCIENCES INC·Filed 2022·Granted Jan 16, 2024·1 cites·17 claims
2193US11364302B1Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES INC·Filed 2021·Granted Jun 21, 2022·2 cites·20 claims
2289US2024287522A1Compositions and methods of treating facioscapulohumeral muscular dystrophyAVIDITY BIOSCIENCES INC·Filed 2024·Application pending·0 cites
2389US2025340880A1Compositions and methods of treating facioscapulohumeral muscular dystrophyAVIDITY BIOSCIENCES INC·Filed 2025·Application pending·0 cites
2488US12486328B2Compositions and methods of treating facioscapulohumeral muscular dystrophyAVIDITY BIOSCIENCES INC·Filed 2025·Granted Dec 2, 2025·0 cites·19 claims
2588US2024400707A1Compositions and methods of treating facioscapulohumeral muscular dystrophyAVIDITY BIOSCIENCES INC·Filed 2024·Application pending·0 cites
2687US2025381285A1Compositions and methods of treating muscle dystrophyAVIDITY BIOSCIENCES INC·Filed 2025·Application pending·0 cites
2786US12263224B2Compositions and methods of treating muscle atrophy and myotonic dystrophyAVIDITY BIOSCIENCES INC·Filed 2022·Granted Apr 1, 2025·0 cites·15 claims
2885US2023047754A1Compositions and methods of treating muscle atrophy and myotonic dystrophyAVIDITY BIOSCIENCES INC·Filed 2022·Application pending·0 cites
2981US11712478B2Compositions and methods of treating muscle atrophy and myotonic dystrophyAVIDITY BIOSCIENCES INC·Filed 2021·Granted Aug 1, 2023·0 cites·13 claims
3078US2025195676A1Compositions and methods of treating muscle atrophy and myotonic dystrophyAVIDITY BIOSCIENCES INC·Filed 2025·Application pending·0 cites
3174US12364769B2Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES INC·Filed 2021·Granted Jul 22, 2025·0 cites·12 claims
3272US2025152726A1Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES INC·Filed 2025·Application pending·0 cites

Join the waitlist — get patent alerts

Get an alert when Barbora Malecova files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →